series-a
Stage
About
Endowave develops the FlexABLATE transbronchial microwave ablation system, a medical device designed to deliver minimally invasive robotic-bronchoscopy-guided treatment for lung cancer, currently undergoing clinical evaluation in Europe and raising Series A funding to pursue CE marking and US regulatory approval.
Explore Endowave's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.